Atherosclerosis, inflammation, and CAD pathology

Cardiology Review

Volumn 18, Issue 7, 2001, Pages 37-40

  Zasadil, M ^a   Mormando, R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HUMAN; INFLAMMATORY CELL; PATHOPHYSIOLOGY; REVIEW;

EID: 0034972278     PISSN: 10926607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
2. Blood pressure, stroke, and coronary heart disease. Part I, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
3. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
4. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
5. Molecular bases of the acute coronary syndromes
6. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques
7. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
8. Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension
9. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
10. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
11. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
12. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
13. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study
14. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis
15. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease
16. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies
17. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis
18. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (stary grading) of associated atherosclerotic plaque
19. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
20. The anti-inflamatory effects of macrolides
21. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
22. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
23. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction